What Chronic Elevation Actually Does to a Leader’s Brain

The prefrontal cortex, responsible for long-term strategic thinking, impulse regulation, perspective-taking, and complex risk assessment, is acutely sensitive to elevated glucocorticoids. A 2009 study in the Proceedings of the National Academy of Sciences demonstrated that sustained cortisol elevation impairs prefrontal cortex function while simultaneously increasing activity in the amygdala, the brain’s threat-detection and reactive-response centre. The net effect is a predictable cognitive shift: reduced strategic thinking, increased short-termism, and heightened reactivity to perceived threats.

In a mid-level employee, this is a productivity and wellbeing issue. In a senior leader, it is a strategic risk. And the risk compounds: the more authority a cortisol-dysregulated leader holds, the greater the surface area over which their compromised decision-making operates.

Beyond cognitive function, chronic cortisol elevation has measurable social consequences. Research in psychoneuroendocrinology has consistently shown that sustained elevation reduces empathy, specifically the capacity to accurately model other people’s internal states, and increases social aggression and in-group versus out-group threat perception. Leaders in chronic cortisol excess do not become aggressive because they are poor people. Their neurobiology has been driven into a sustained threat state, and that state produces predictable behavioural outputs.

Where Testosterone Enters the Equation

Testosterone’s role in executive function is rarely discussed in leadership development, which is a significant gap given how directly it influences the behaviours that leadership development programmes are trying to shape. Beyond its reproductive and secondary sex characteristic functions, testosterone is a primary driver of confidence, competitive motivation, and risk tolerance. It modulates the social dynamics of status-driven environments. It is closely associated with expansive, approach-oriented behaviour: the willingness to engage with challenge rather than avoid it, to hold a position under pressure, and to act decisively when information is incomplete.

The research on power, posture, and hormonal state has been substantially replicated across laboratory and field settings. Individuals who have recently experienced status-affirming social interactions, a successful negotiation, a credible public performance, the exercise of authority, show measurable increases in testosterone. The reverse is also true: status threat, social rejection, and repeated experience of powerlessness drive testosterone down.

What makes the testosterone story particularly relevant for organisations is the bidirectional relationship between hormonal state and behaviour. Testosterone does not merely reflect confidence; it produces it. It does not merely accompany decisive action; it enables it.

The T:C Ratio: A Working Index of Leadership Readiness

The testosterone-to-cortisol ratio (T:C) functions as a rough but clinically useful index of biological readiness for the demands of senior leadership. The two profiles it distinguishes are not personality types. They are hormonal states, and hormonal states are modifiable.

In more than two decades of working with senior leaders across sectors, what becomes clear is that many of the most intelligent, experienced, and technically capable leaders are running on cortisol-dominant hormonal profiles. They are not underperforming by the metrics their organisations use to measure them. But their T:C ratio tells a different story.

Cortisol-dominant leaders produce specific, recognisable organisational signatures. Their teams become risk-averse, because the leader’s behavioural bias toward threat and caution filters down. Strategic planning sessions lack genuine ambition, because expansive thinking requires a hormonal state that chronic stress suppresses. High-potential people leave, because they sense, accurately, that the environment does not support the kind of bold, confident action they want to engage in.

The Mechanism of Cortisol-Testosterone Suppression

One specific pathway is worth understanding directly: cortisol suppresses testosterone synthesis via competitive inhibition of steroidogenic pathways.

Both cortisol and testosterone are steroid hormones synthesised from cholesterol through a shared precursor, pregnenolone. Under conditions of sustained stress, the body preferentially allocates pregnenolone toward cortisol production; this is sometimes called “pregnenolone steal”, though the full mechanism is more complex. The result is reduced substrate available for testosterone synthesis. Additionally, chronically elevated cortisol suppresses the hypothalamic-pituitary-gonadal (HPG) axis directly, reducing the signalling cascade that drives testosterone production.

The hormonal signature of depleted leadership is characterised by high anxiety, low confidence, reduced competitive drive, diminished risk tolerance, and reactive decision-making. It is not a mindset problem. It is the biological output of this suppression pathway running continuously over months or years.

That means sleep architecture, training load and recovery, nutritional protocols that support steroidogenesis, and the removal of chronic stressors that keep the HPA axis in sustained activation. This is why leadership biology is not a peripheral concern. It is the foundation on which everything else rests.

What This Means for Organisations

For CHROs and people functions, the implication is direct: leadership effectiveness assessment that does not account for the physiological state of senior leaders is missing a primary determinant of the outcomes being assessed.

A senior leader’s strategic quality, their capacity to build high-performance culture, their ability to hold difficult conversations and make sound decisions under pressure, all of these are downstream of their hormonal and neurobiological state. Measuring only the outputs while ignoring the biological inputs produces an incomplete picture and leads to interventions that address symptoms rather than causes.

The organisations that will build sustainably high-performing leadership cultures are the ones that treat executive physiological health not as a personal wellness concern but as a business-critical variable, one that is measurable, modifiable, and directly tied to the decisions being made at the top of the organisation. A practical audit to start with: